TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T02501 XX ID T02501 XX DT 17.07.1998 (created); ewi. DT 19.11.2007 (updated); pch. CO Copyright (C), QIAGEN. XX FA MEF-2B2 XX SY MEF-2B type B-2; MEF-2B-2. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G014309 Mef2b. XX CL C0014; MADS. XX SZ 339 AA; 36.6 kDa (cDNA) (calc.). XX SQ MGRKKIQISRILDQRNRQVTFTKRKFGLMKKAYELSVLCDCDIALIIFNSAQRLFQYASS SQ DMDRVLLKYTEYSEPHESRTNADILQTLKRRGVGLDGPELDMEEGPEGPGEKLLRTLGGD SQ RGSASPRPRIYPVAPAMSVSELSYRVPPATPGCDPGGLGEVPSVHSRPAYFRPPGLGHPI SQ FSPSHLASKTPPPLYLATDGRRPDLPPGLRSLYSGLQSPGAPGPALGSFAFLPSGSTDCS SQ PGDAAQGPLQPSPWPPTRDAVDPARPVARSLCKEGPPSRGASPPTPPVSIKSERLSPVTG SQ TSGDFPRSFPYPLLLARPLAEPLRPSASLHRLTPDSWPR XX SC PIR #JC5882 XX FT 1 60 SM00432; MADS. FT 1 61 PS50066; MADS_BOX_2. FT 9 59 PF00319; SRF-type transcription factor (DNA-binding a. XX SF alternative splice variants are MEF-2B-1 T01785, MEF-2B-3 T02502 and MEF-2B-4 T02503 [2]; XX CP (embryo:) heart, skeletal muscle (before 14 dpc); (adult:) testis [2]. CN (adult:) brain, heart, skeletal muscle [2]. XX FF transcriptional activator, exhibiting about 39% of human MEF-2A activity [2]; XX DR TRANSPATH: MO000026482. DR EMBL: D87831; DR EMBL: D87835; DR UniProtKB: O55087-2; XX RN [1]; RE0006949. RX PUBMED: 8668199. RA Molkentin J. D., Firulli A. B., Black B. L., Martin J. F., Hustad C. M., Copeland N., Jenkins N., Lyons G., Olson E. N. RT MEF2B is a potent transactivator expressed in early myogenic lineages RL Mol. Cell. Biol. 16:3814-3824 (1996). RN [2]; RE0006950. RX PUBMED: 9443808. RA Morisaki T., Sermsuvitayawong K., Byun S. H., Matsuda Y., Hidaka K., Morisaki H., Mukai T. RT Mouse Mef2b gene: unique member of MEF2 gene family RL J. Biochem. 122:939-946 (1997). XX //